MCGRATH DENNIS M 4
4 · PAVmed Inc. · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
PAVmed (PAVM) President/CFO Dennis McGrath Receives 180,000-Share Award
What Happened
Dennis M. McGrath, PAVmed’s President and Chief Financial Officer, received an award of 180,000 restricted shares on April 2, 2026. The shares were granted at a $0.00 per-share price (awarded, not purchased) — total cash consideration recorded is $0. This is a compensation award, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-02 (Form filed 2026-04-03; filing appears timely).
- Transaction type/code: Award/Grant (A).
- Shares granted: 180,000 restricted common shares; grant price listed as $0.00.
- Shares owned after transaction: not specified in the filing.
- Footnote: These restricted shares vest on a single date, May 20, 2029, and are subject to forfeiture if the requisite service period is not completed (per F1).
- No 10b5-1 plan, tax-withholding sale, or cash exercise involved (none reported).
Context
Restricted stock awards are a form of compensation intended to align executives with long-term shareholder value; they are not an immediate vote of bullish or bearish sentiment because they typically cannot be sold until vested. The May 20, 2029 vesting date means these shares are illiquid for several years and may be forfeited if McGrath leaves before vesting.
Insider Transaction Report
- Award
Common stock
[F1]2026-04-02+180,000→ 186,695 total
Footnotes (1)
- [F1]Represents restricted stock granted to the reporting person under the Issuer's Seventh Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed.